Longevity Market Shifts: Consumer Health, GLP-1 Impact, and Strategic Optimization
The longevity sector is transitioning from speculative biotech to scalable consumer lifestyle optimization. This analysis examines GLP-1 driven retail disruptions, plant-based protein substitution, and data-driven wellness tracking. Strategic frameworks for investors and founders prioritize accessible healthspan solutions over extreme interventions.